Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-07-17
2007-07-17
Lewis, Patrick (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S042000, C514S045000, C514S043000
Reexamination Certificate
active
10809060
ABSTRACT:
In accordance with the present invention there is provided a pharmaceutical composition useful for the treatment or prophylaxis of viral infections comprising tipranavir and at least one antiviral active compound of formula (I)wherein Base is selected from the group consisting of thymine, cytosine, adenine, guanine, inosine, uracil, 5-ethyluracil and 2,6-diaminopurine, or a pharmaceutically acceptable salt or prodrug thereof.
REFERENCES:
patent: 6147095 (2000-11-01), Ferry et al.
patent: 2001/0036920 (2001-11-01), Hirschman
patent: WO 88/00050 (1988-01-01), None
patent: WO 91/01137 (1991-02-01), None
patent: WO 99/09031 (1999-02-01), None
patent: WO 99/41268 (1999-08-01), None
patent: WO 00/51641 (2000-09-01), None
Roy M. Gulick et al; New drugs for HIV therapy; AIDS (2002) vol. 16 No. 4 pp. S135-S144; Lippincott Williams & Wilkins.
Erik De Clercq; New Developments in Anti-HIV Chemotherapy; Current Medicinal Chemistry (2001) vol. 8 pp. 1543-1572; Bentham Science Publishers Ltd.
Klaes Heinz-Gerd
Koundourakis Elena
Mayers Douglas Lytle
Valdez Hernan
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Lewis Patrick
Morris Michael P.
LandOfFree
Pharmaceutical composition of antiviral agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition of antiviral agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition of antiviral agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3742361